Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Encainide (MJ9067), a class IC antiarrhythmic drug, holds potential for research into life-threatening and symptomatic ventricular arrhythmias as well as supraventricular arrhythmias.
Description | Encainide (MJ9067), a class IC antiarrhythmic drug, holds potential for research into life-threatening and symptomatic ventricular arrhythmias as well as supraventricular arrhythmias. |
In vivo | Encainide, administered in single doses via infusion at 0.3, 0.9, and 2.7 mg/kg, extends the His-Purkinje conduction time (HV interval) and intra-ventricular conduction time (QRS duration). However, it does not influence the sinus nodal recovery time or the AV nodal conduction. Additionally, it does not affect the refractoriness of the atrium, AV node, or ventricular myocardium, nor does it impact the QT interval[1]. |
Synonyms | Encainide, MJ9067 |
Molecular Weight | 352.478 |
Formula | C22H28N2O2 |
CAS No. | 66778-36-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Encainide 66778-36-7 Others MJ9067 MJ-9067 MJ 9067 inhibitor inhibit